{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:00:51Z","timestamp":1788782451113,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effects of thymectomy on late-onset non-thymomatous myasthenia gravis (NTMG) remain controversial. The objective of this study was to conduct a systematic review in order to answer two questions pertinent to late-onset NTMG: (1) do patients with late-onset NTMG experience the same effects from thymectomy as their early-onset counterparts? (2) Compared with conservative treatment, does thymectomy have any benefits for late-onset NTMG patients?<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched the PubMed, EMBASE, and Cochrane Library databases for studies published from January 1, 1950 to March 10, 2021. Outcomes were measured via clinical stable remission\/pharmacological remission (CSR\/PR) and improvement rates. We used Stata software to analyze the data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We ultimately included a total of 12 observational articles representing the best evidence answering the questions of our study objective. Of these, nine studies, which included 896 patients overall (766 early-onset and 230 late-onset), compared postoperative outcomes between early- and late-onset NTMG. The remaining three articles, which included 216 patients (75 in the thymectomy group and 141 in the conservative-treatment group), compared thymectomy with conservative treatment for late-onset NTMG. The early- versus late-onset NTMG studies demonstrated that patients in the former category were 1.95\u00d7 likelier than their late-onset counterparts to achieve clinical remission (odds ratio [OR] 1.95; 95% confidence interval [CI] 1.39\u20132.73; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090%). No difference was seen in improvement or remission\u2009+\u2009improvement rates between these two groups. When comparing thymectomy with conservative treatments in late-onset NTMG patients, neither did we observe any difference in CSR\/PR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We found that late-onset NTMG patients had a lower chance of achieving CSR after thymectomy than early-onset patients. Thymectomy in late-onset NTMG also yielded no benefit to CSR or PR compared with conservative treatments. In late-onset NTMG patients, thymectomy should therefore be performed with caution, and the appropriate cutoff between early- and late-onset MG should be further explored in order to tailor and execute the proper therapeutic strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01860-y","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:09:10Z","timestamp":1621537750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Jinwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3481-9439","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"issue":"1","key":"1860_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren J. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"1860_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8(5):475\u201390.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1860_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JND-140045","volume":"2","author":"JC Deenen","year":"2015","unstructured":"Deenen JC, Horlings CG, Verschuuren JJ, Verbeek AL, van Engelen BG. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis. 2015;2(1):73\u201385.","journal-title":"J Neuromuscul Dis"},{"key":"1860_CR4","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.lanwpc.2020.100063","volume":"5","author":"J Chen","year":"2020","unstructured":"Chen J, Tian D-C, Zhang C, Li Z, Zhai Y, Xiu Y, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study. Lancet Region Health West Pac. 2020;5:100063.","journal-title":"Lancet Region Health West Pac"},{"issue":"9","key":"1860_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s40266-015-0297-2","volume":"32","author":"NM Alkhawajah","year":"2015","unstructured":"Alkhawajah NM, Oger J. Treatment of myasthenia gravis in the aged. Drugs Aging. 2015;32(9):689\u201397.","journal-title":"Drugs Aging"},{"issue":"1","key":"1860_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archneur.56.1.25","volume":"56","author":"JA Aarli","year":"1999","unstructured":"Aarli JA. Late-onset myasthenia gravis: a changing scene. Arch Neurol. 1999;56(1):25\u20137.","journal-title":"Arch Neurol"},{"issue":"10","key":"1860_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023\u201336.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1860_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Str\u00f6bel P. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev. 2013;12(9):875\u201384.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1860_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419\u201325.","journal-title":"Neurology"},{"issue":"6","key":"1860_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, et al. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 2016;375(6):511\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"1860_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1468-1331.2002.00352.x","volume":"9","author":"F Romi","year":"2002","unstructured":"Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. Eur J Neurol. 2002;9(1):55\u201361.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1860_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejcts.2009.05.027","volume":"37","author":"MW Lin","year":"2010","unstructured":"Lin MW, Chang YL, Huang PM, Lee YC. Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors. Eur J Cardiothorac Surg. 2010;37(1):7\u201312.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10","key":"1860_CR13","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.clineuro.2007.08.006","volume":"109","author":"N Kawaguchi","year":"2007","unstructured":"Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Arimura K, Osame M, et al. Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin Neurol Neurosurg. 2007;109(10):858\u201361.","journal-title":"Clin Neurol Neurosurg"},{"key":"1860_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00415-015-7673-z","volume":"262","author":"A Uzawa","year":"2015","unstructured":"Uzawa A, Kawaguchi N, Kanai T, Himuro K, Oda F, Yoshida S, et al. Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. J Neurol. 2015;262:1019\u201323.","journal-title":"J Neurol."},{"issue":"4","key":"1860_CR15","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00415-019-09222-2","volume":"266","author":"SW Kim","year":"2019","unstructured":"Kim SW, Choi YC, Kim SM, Shim HS, Shin HY. Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis. J Neurol. 2019;266(4):960\u20138.","journal-title":"J Neurol"},{"issue":"1","key":"1860_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","volume":"70","author":"A Jaretzki III","year":"2000","unstructured":"Jaretzki A III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg. 2000;70(1):327\u201334.","journal-title":"Ann Thorac Surg."},{"issue":"1","key":"1860_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"issue":"9","key":"1860_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"1860_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.295.6.676","volume":"295","author":"JL Peters","year":"2006","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676\u201380.","journal-title":"JAMA"},{"issue":"5","key":"1860_CR20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/icvts\/ivv176","volume":"21","author":"Z Liu","year":"2015","unstructured":"Liu Z, Yang J, Lin L, Huang J, Jiang G. Unilateral video-assisted thoracoscopic extended thymectomy offers long-term outcomes equivalent to that of the bilateral approach in the treatment of non-thymomatous myasthenia gravis. Interact Cardiovasc Thorac Surg. 2015;21(5):610\u20135.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"1860_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.athoracsur.2003.11.040","volume":"78","author":"M Zieli\u0144ski","year":"2004","unstructured":"Zieli\u0144ski M, Kuzdzal J, Szlubowski A, Soja J. Comparison of late results of basic transsternal and extended transsternal thymectomies in the treatment of myasthenia gravis. Ann Thorac Surg. 2004;78(1):253\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"1\u20132","key":"1860_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0022-510X(03)00087-X","volume":"212","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Bernasconi P, Antozzi C, Confalonieri P, Novellino L, et al. Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J Neurol Sci. 2003;212(1\u20132):31\u20136.","journal-title":"J Neurol Sci"},{"issue":"5","key":"1860_CR23","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0022-5223(96)70151-4","volume":"112","author":"MJ Mack","year":"1996","unstructured":"Mack MJ, Landreneau RJ, Yim AP, Hazelrigg SR, Scruggs GR, Kirschner PA, et al. Results of video-assisted thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg. 1996;112(5):1352\u201360.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"1860_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0003-4975(94)90993-8","volume":"57","author":"WH Frist","year":"1994","unstructured":"Frist WH, Thirumalai S, Doehring CB, Merrill WH, Stewart JR, Fenichel GM, et al. Thymectomy for the myasthenia gravis patient: Factors influencing outcome. Ann Thorac Surg. 1994;57(2):334\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"1860_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/1010-7940(89)90109-7","volume":"3","author":"G Maggi","year":"1989","unstructured":"Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymectomy in myasthenia gravis. Results of 662 cases operated upon in 15 years. Eur J Cardio-Thorac Surg. 1989;3(6):504\u20139 (discussion 10\u201311).","journal-title":"Eur J Cardio-Thorac Surg"},{"issue":"5","key":"1860_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0003-4975(10)61951-0","volume":"39","author":"Y Monden","year":"1985","unstructured":"Monden Y, Nakahara K, Fujii Y. Myasthenia gravis in elderly patients. Ann Thorac Surg. 1985;39(5):433\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"1860_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0022-5223(19)39268-2","volume":"82","author":"JW Rubin","year":"1981","unstructured":"Rubin JW, Ellison RG, Moore HV, Pai GP. Factors affecting response to thymectomy for myasthenia gravis. J Thorac Cardiovasc Surg. 1981;82(5):720\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"16","key":"1860_CR28","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1212\/WNL.0000000000009294","volume":"94","author":"GS Gronseth","year":"2020","unstructured":"Gronseth GS, Barohn R, Narayanaswami P. Practice advisory: thymectomy for myasthenia gravis (practice parameter update): report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2020;94(16):705\u20139.","journal-title":"Neurology"},{"issue":"10","key":"1860_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/jnnp.52.10.1121","volume":"52","author":"HJ Oosterhuis","year":"1989","unstructured":"Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry. 1989;52(10):1121\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"1860_CR30","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1212\/WNL.0000000000008903","volume":"94","author":"E Cort\u00e9s-Vicente","year":"2020","unstructured":"Cort\u00e9s-Vicente E, \u00c1lvarez-Velasco R, Segovia S, Paradas C, Casasnovas C, Guerrero-Sola A, et al. Clinical and therapeutic features of myasthenia gravis in adults based on age at onset. Neurology. 2020;94(11):e1171\u201380.","journal-title":"Neurology"},{"issue":"4","key":"1860_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.surg.2008.11.009","volume":"145","author":"K Bachmann","year":"2009","unstructured":"Bachmann K, Burkhardt D, Schreiter I, Kaifi J, Schurr P, Busch C, et al. Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement. Surgery. 2009;145(4):392\u20138.","journal-title":"Surgery"},{"key":"1860_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13023-014-0214-5","volume":"9","author":"C Barnett","year":"2014","unstructured":"Barnett C, Katzberg HD, Keshavjee S, Bril V. Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study. Orphanet J Rare Dis. 2014;9:214.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1860_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-018-0837-z","volume":"13","author":"AJM Cataneo","year":"2018","unstructured":"Cataneo AJM, Felisberto G Jr, Cataneo DC. Thymectomy in nonthymomatous myasthenia gravis\u2014systematic review and meta-analysis. Orphanet J Rare Dis. 2018;13(1):99.","journal-title":"Orphanet J Rare Dis"},{"key":"1860_CR34","doi-asserted-by":"crossref","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2020.","DOI":"10.1212\/WNL.0000000000011124"},{"issue":"4","key":"1860_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00415-015-7673-z","volume":"262","author":"A Uzawa","year":"2015","unstructured":"Uzawa A, Kawaguchi N, Kanai T, Himuro K, Oda F, Yoshida S, et al. Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. J Neurol. 2015;262(4):1019\u201323.","journal-title":"J Neurol"},{"key":"1860_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneuroim.2017.01.005","volume":"305","author":"K Nakahara","year":"2017","unstructured":"Nakahara K, Nakane S, Nakajima M, Yamashita S, Mori T, Ando Y. Effect of thymectomy for thymic atrophy in myasthenia gravis: a retrospective study on 93 patients. J Neuroimmunol. 2017;305:182\u20135.","journal-title":"J Neuroimmunol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01860-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:12:33Z","timestamp":1621537953000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01860-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01860-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"13 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Tianjin Medical University General Hospital (Tianjin, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We were exempted from obtaining informed consent because this was a secondary analysis of previously published studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Written informed consent for publication was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}